This study found that the incidence of EGFR mutation in women, adenocarcinoma, and non‐smokers is significantly higher than that in men, squamous cell carcinoma, and smokers, and the differences between these groups are statistically significant. This evidence concerns the gene EGFR and adenocarcinoma.